The Serum Institute of India has informed the central government that it will be able to manufacture and supply 10 crore doses of its anti-coronavirus vaccine, Covishield in June. "We are pleased to inform that in June we will be able to manufacture and supply nine to 10 crore doses of our Covishield vaccine to the country as compared to our production capacity of 6.5 crore doses in May," Prakash Kumar Singh, the Director of Government and Regulatory Affairs at SII, said in the letter. In early May, SII had communicated to the Centre that production of Covishield would be ramped up to 6.5 crore in June, seven crore in July and 10 crore each in August and September. "Serum Institute of India has always been sincerely concerned about the protection of the citizens of our country and world at large from COVID-19. India is currently using made-in-India vaccines -- Covishield manufactured by SII and Covaxin of Bharat Biotech -- in its Covid-19 vaccination drive.

Source: Mint May 30, 2021 12:33 UTC